# Actimis Pharmaceuticals Inc — Form D

Actimis Pharmaceuticals Inc of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-19. The offering totals $1.0M, of which $452K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-06-19
- Form: D
- Accession: 0001313836-17-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $452K
- Remaining: $548K
- Investors: 5
- Date of first sale: 2017-03-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-288964

## Issuer

- Name: Actimis Pharmaceuticals Inc
- CIK: 0001313836
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 S. El Camino Real, Suite 1200, San Mateo, CA, 94402
- Phone: 650-401-2000

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kevin Bacon | Director | Santa Ana, CA |
| Masaji Matsuoka | Director | San Mateo, CA |
| Peter McWilliams | Director | San Mateo, CA |
| Fred Middleton | Director | La Jolla, CA |
| Kevin Bacon | Executive Officer | Santa Ana, CA |
| Peter McWilliams | Executive Officer | San Mateo, CA |

## More

- [CIK 1313836 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1313836&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001313836-17-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.